期刊名称:ACSPharmacology&TranslationalScience
作者:JonKObst,JunWang,KunzhongJian,ms,
年份:2019年
期号:第XXXX期
关键词:UDP-glucuronosyltransfera(UGT2B);ralaniten;drug
resistance;androgenreceptor
摘要:Inhibitionofandrogenreceptor(AR)isthemainstaytreatmentfor
ten(formallyEPI-002)preventsARtranscriptional
activitybybindingtoitsN-terminaldomain(NTD)whichisntialfor
tenacetate(EPI-506)thetri-acetatepro-drugof
ralaniten,remainstheonlyAR-NTDinhibitortohaveenteredclinicaltrials
(NCT02606123).Whilewelltolerated,thetrialwasultimatelyterminateddueto
discoveredthat
-term
treatmentofprostatecancercellswithralanitenresultsinupregulationofUGT2B
sprovedaufulmodelwith
whichtofacilitatethedevelopmentofmorepotent...
内容由中国教育图书进出口有限公司引进
RevealingMetabolicLiabilitiesofRalanitenTo
EnhanceNovelAndrogenReceptorTargeted
Therapies
本文发布于:2022-11-24 06:22:19,感谢您对本站的认可!
本文链接:http://www.wtabcd.cn/fanwen/fan/90/10016.html
版权声明:本站内容均来自互联网,仅供演示用,请勿用于商业和其他非法用途。如果侵犯了您的权益请与我们联系,我们将在24小时内删除。
留言与评论(共有 0 条评论) |